Ultrasonographic and Laboratory Markers of Metabolic and Cardiovascular Disease Risk in Obese Women with Polycystic Ovary Syndrome

    February 2012
    Lucimara Facio Nobre Zueff, Wellington P. Martins, Carolina Sales Vieira, Rui Alberto Ferriani
    Image of study
    TLDR Obese women with PCOS are more likely to have fatty liver disease.
    The study investigated the relationship between polycystic ovary syndrome (PCOS) and markers of metabolic and cardiovascular disease risk in 90 obese women, with 45 diagnosed with PCOS and 45 serving as age-matched controls. The results indicated that women with PCOS had a significantly higher prevalence of non-alcoholic fatty liver disease (NAFLD) (73.3% vs. 46.7%, P < 0.01) and a higher free androgen index (FAI) (10.4% vs. 6.8%, P < 0.01). Additionally, there was a trend towards higher insulin levels and lower insulin sensitivity (as measured by QUICKI) and reduced flow-mediated dilation (FMD) of the brachial artery in the PCOS group, although these were not statistically significant. The study concluded that NAFLD is more common in obese women with PCOS, which is an important consideration for their healthcare, including the choice of contraceptives.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  445 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Similar Research

    5 / 1000+ results